Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22253485 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Genetic and Environmental Factors and Their Effect on Response to Treatment With Lucentis (Ranibizumab) for Wet AMD
Condition: Macular Degeneration
Intervention: Drug: Ranibizumab

Indicates status has not been verified in more than two years